Cargando…

Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?

Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Carta, Mauro Giovanni, Kalcev, Goce, Scano, Alessandra, Pinna, Samantha, Gonzalez, Cesar Ivan Aviles, Nardi, Antonio Egidio, Orrù, Germano, Primavera, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453758/
https://www.ncbi.nlm.nih.gov/pubmed/37623258
http://dx.doi.org/10.3390/clinpract13040077
_version_ 1785096018352668672
author Carta, Mauro Giovanni
Kalcev, Goce
Scano, Alessandra
Pinna, Samantha
Gonzalez, Cesar Ivan Aviles
Nardi, Antonio Egidio
Orrù, Germano
Primavera, Diego
author_facet Carta, Mauro Giovanni
Kalcev, Goce
Scano, Alessandra
Pinna, Samantha
Gonzalez, Cesar Ivan Aviles
Nardi, Antonio Egidio
Orrù, Germano
Primavera, Diego
author_sort Carta, Mauro Giovanni
collection PubMed
description Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 61, ≥60 years) received a clinical psychiatric evaluation, the MDQ, and were evaluated according to the presence of the genetic variant RS1006737 of CACNA1C. MDQ+ versus the diagnosis of BD as a gold standard shows a sensitivity of 0.286 (Cl 95% 0.14–0.39); a specificity of 0.925 (Cl 95% 0.85–0.08); a predictive positive value (PPV) of 0.667 (Cl 95% 0.33–0.91); and a predictive negative value (PNV) of 0.702 (Cl 95% 0.65–0.75). The positivity for the variant RS1006737 of the CACNA1C against the diagnosis of BD as a gold standard shows a sensitivity of 0.750 (Cl 95% 0.55–0.90); a specificity of 0.375 (Cl 95% 0.28–0.45); a PPV of 0.375 (Cl 95% 0.28–0.45); and a PNV of 0.750 (Cl 95% 0.55–0.90). The reliability between the MDQ+ and positivity for the variant RS1006737 of the CACNA1C was very low (K = −0.048, Cl 95% −0.20–0.09). The study found that both the genetic and the paper and pencil test were quite accurate, but were not reliable in case finding. In fact, despite some validity, albeit specular (in the case of a positive genetic test, the probability of having the disorder is very high, whereas in the case of a negative score on the paper and pencil test, the probability of not having the disorder is very high), the unreliability of the two tests (i.e., they certainly do not measure the same underlying dimension) opens the door to the need for an interpretation and the possibility of a synergistic use for screening. From a heuristic perspective, which obviously requires all of the necessary verifications, this study seems to suggest the hypothesis that a condition of hyperactivation common to disorders and stress conditions, and identified by a positive score on the MDQ (which is common to BD, post-traumatic stress disorder (PTSD), and anxiety disorders and whose genetic basis has not yet been clarified) can trigger BD in people with a predisposition to hyperactivity (i.e., in people with the condition identified by the analyzed genetic variant).
format Online
Article
Text
id pubmed-10453758
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104537582023-08-26 Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? Carta, Mauro Giovanni Kalcev, Goce Scano, Alessandra Pinna, Samantha Gonzalez, Cesar Ivan Aviles Nardi, Antonio Egidio Orrù, Germano Primavera, Diego Clin Pract Article Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 61, ≥60 years) received a clinical psychiatric evaluation, the MDQ, and were evaluated according to the presence of the genetic variant RS1006737 of CACNA1C. MDQ+ versus the diagnosis of BD as a gold standard shows a sensitivity of 0.286 (Cl 95% 0.14–0.39); a specificity of 0.925 (Cl 95% 0.85–0.08); a predictive positive value (PPV) of 0.667 (Cl 95% 0.33–0.91); and a predictive negative value (PNV) of 0.702 (Cl 95% 0.65–0.75). The positivity for the variant RS1006737 of the CACNA1C against the diagnosis of BD as a gold standard shows a sensitivity of 0.750 (Cl 95% 0.55–0.90); a specificity of 0.375 (Cl 95% 0.28–0.45); a PPV of 0.375 (Cl 95% 0.28–0.45); and a PNV of 0.750 (Cl 95% 0.55–0.90). The reliability between the MDQ+ and positivity for the variant RS1006737 of the CACNA1C was very low (K = −0.048, Cl 95% −0.20–0.09). The study found that both the genetic and the paper and pencil test were quite accurate, but were not reliable in case finding. In fact, despite some validity, albeit specular (in the case of a positive genetic test, the probability of having the disorder is very high, whereas in the case of a negative score on the paper and pencil test, the probability of not having the disorder is very high), the unreliability of the two tests (i.e., they certainly do not measure the same underlying dimension) opens the door to the need for an interpretation and the possibility of a synergistic use for screening. From a heuristic perspective, which obviously requires all of the necessary verifications, this study seems to suggest the hypothesis that a condition of hyperactivation common to disorders and stress conditions, and identified by a positive score on the MDQ (which is common to BD, post-traumatic stress disorder (PTSD), and anxiety disorders and whose genetic basis has not yet been clarified) can trigger BD in people with a predisposition to hyperactivity (i.e., in people with the condition identified by the analyzed genetic variant). MDPI 2023-07-27 /pmc/articles/PMC10453758/ /pubmed/37623258 http://dx.doi.org/10.3390/clinpract13040077 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Carta, Mauro Giovanni
Kalcev, Goce
Scano, Alessandra
Pinna, Samantha
Gonzalez, Cesar Ivan Aviles
Nardi, Antonio Egidio
Orrù, Germano
Primavera, Diego
Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
title Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
title_full Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
title_fullStr Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
title_full_unstemmed Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
title_short Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
title_sort screening, genetic variants, and bipolar disorders: can useful hypotheses arise from the sum of partial failures?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453758/
https://www.ncbi.nlm.nih.gov/pubmed/37623258
http://dx.doi.org/10.3390/clinpract13040077
work_keys_str_mv AT cartamaurogiovanni screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT kalcevgoce screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT scanoalessandra screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT pinnasamantha screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT gonzalezcesarivanaviles screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT nardiantonioegidio screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT orrugermano screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures
AT primaveradiego screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures